John Oates: A closer look pg. 9
He singles out two awards as most meaningful to him, one from early in his career: the American Society for Pharmacology and Experimental Therapeutics Award for “Outstanding Basic Pharmacologic Investigations in Man;” and one from just last year, an Award of Excellence in Clinical Research from the General Clinical Research Centers Program of the NIH. These awards applaud the hypothesis-driven clinical research that has distinguished his career.
Central to such research is the patient, and Oates has never lost sight of his calling as a physician.
Robertson is one of the more than 300 fellows who have trained in the Division of Clinical Pharmacology at Vanderbilt. About a third of them have gone on to leadership positions in either academia or industry related to drug discovery and development.
This legacy of success will be extended in the John A. Oates Institute for Experimental Therapeutics.
“This institute recognizes Vanderbilt’s commitment to growing the kind of science that John made famous here—understanding how drugs work in the body, why not everyone responds to drugs the same way, and how we can use that information to make better use of the drugs we have and to develop new drugs,” says Dan M. Roden, M.D., director of the Oates Institute and former director of Clinical Pharmacology.
As the new institute blooms and begins to flourish, Oates will be watching.